Literature DB >> 28335890

Cervical cancer incidence in elderly women-biology or screening history?

Elsebeth Lynge1, Stefan Lönnberg2, Sven Törnberg3.   

Abstract

AIM: In many countries, the age-specific pattern of cervical cancer incidence is currently bipolar with peaks at for instance 45 and 65 years of age. Consequently, a large proportion of cervical cancer cases are presently diagnosed in women above the screening age. The purpose of the study was to determine whether this bipolar pattern in age-specific incidence of cervical cancer reflects underlying biology or can be explained by the fact that the data come from birth cohorts with different screening histories.
METHODS: Combination of historical data on cervical screening and population-based cancer incidence data from Denmark 1943-2013, Finland and Norway 1953-2013, and Sweden 1958-2013.
RESULTS: Since the implementation of screening, the incidence of cervical cancer has decreased for each successive birth cohort. All birth cohorts showed a unipolar age-specific pattern. In unscreened women in Denmark and Sweden, the incidence peaked around the age of 50; the peak was less marked in Finland; while peak age for unscreened women could not be determined for Norway due to widespread opportunistic screening. The current old-age peak in the incidence of cervical cancer represents residuals from unscreened or underscreened birth cohorts.
CONCLUSION: The current bipolar pattern in age-specific incidence of cervical cancer can largely be explained by the different screening histories of successive birth cohorts. While it is reasonable to offer screening to elderly women today, birth cohort trends in disease burden should be carefully monitored to justify permanent changes in upper screening age.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Cervix uteri; Screening

Mesh:

Year:  2017        PMID: 28335890     DOI: 10.1016/j.ejca.2016.12.021

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  8 in total

1.  Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden.

Authors:  Jiangrong Wang; Bengt Andrae; Karin Sundström; Alexander Ploner; Peter Ström; K Miriam Elfström; Joakim Dillner; Pär Sparén
Journal:  PLoS Med       Date:  2017-10-24       Impact factor: 11.069

2.  Trends in cervical cancer incidence and survival in Estonia from 1995 to 2014.

Authors:  Kristiina Ojamaa; Kaire Innos; Aleksei Baburin; Hele Everaus; Piret Veerus
Journal:  BMC Cancer       Date:  2018-11-07       Impact factor: 4.430

3.  Effectiveness of cervical cancer screening at age 65 - A register-based cohort study.

Authors:  Maiju Pankakoski; Ahti Anttila; Tytti Sarkeala; Sirpa Heinävaara
Journal:  PLoS One       Date:  2019-03-26       Impact factor: 3.240

4.  Histological outcomes in HPV-screened elderly women in Denmark.

Authors:  Gry St-Martin; Petra Hall Viborg; Ane Birgitte Telén Andersen; Berit Andersen; Jette Christensen; Dorthe Ejersbo; Hanne Nørgaard Heje; Kirsten Marie Jochumsen; Tonje Johansen; Lise Grupe Larsen; Elsebeth Lynge; Reza Rafiolsadat Serizawa; Marianne Waldstrøm
Journal:  PLoS One       Date:  2021-02-11       Impact factor: 3.240

5.  LncRNA ABHD11-AS1 Participates in the Progression of Cervical Carcinoma by Targeting miR-1254 and Is the Key to the Diagnosis and Treatment of Cervical Carcinoma in the Future.

Authors:  Duanrong Zhu; Qun Hao; Min Qian; Yuli Hu; Feifei Wu
Journal:  J Healthc Eng       Date:  2022-02-10       Impact factor: 2.682

6.  Study of the biological function of LncRNA LUCAT1 on cervical cancer cells by targeting miR-199b-5p.

Authors:  Ting Yang; Shengnan Xia
Journal:  Biosci Rep       Date:  2020-04-30       Impact factor: 3.840

7.  Screening history and FIGO-stages among Danish women with cervical cancer in 2012-2014: a register-based study.

Authors:  Abir Khalil Bchtawi; Sinem Saritas; Doris Schledermann; René dePont Christensen; Kirsten Marie Jochumsen
Journal:  Sci Rep       Date:  2019-12-31       Impact factor: 4.379

8.  Expanding the upper age limit for cervical cancer screening: a protocol for a nationwide non-randomised intervention study.

Authors:  Mette Tranberg; Lone Kjeld Petersen; Klara Miriam Elfström; Anne Hammer; Jan Blaakær; Mary Holten Bennetsen; Jørgen Skov Jensen; Berit Andersen
Journal:  BMJ Open       Date:  2020-11-05       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.